You are here

layoffs

Icon to slash costs amid pandemic as 65% of its trial sites disrupted by COVID-19

Fierce Biotech

Thu, 04/23/20 - 11:02 am

clinical trial recruitment

clinical trials

Survey: Nearly half of medical practices have furloughed workers

MedCity News

Tue, 04/14/20 - 05:00 pm

Sage to lay off half of workforce in cost-cutting retrenchment

BioPharma Dive

Tue, 04/7/20 - 07:47 pm

SAGE Therapeutics

Coronavirus-related layoffs hit health tech startups

Stat

Tue, 04/7/20 - 10:38 am

Halo Neuroscience

Verastem Oncology Sees Strategic Realignment To Reduce Its Operating Expenses By About 40% For 2020

Reuters

Fri, 02/28/20 - 10:46 am

Eloxx cuts staff, CEO and shakes up leadership team

Fierce Biotech

Thu, 02/27/20 - 10:33 am

Eloxx Pharmaceuticals

cystic fibrosis

Wave Life Sciences hits tumultuous waters as ax comes crashing down on staffers

Fierce Biotech

Mon, 02/10/20 - 10:31 am

Wave Life Sciences

Duchenne Muscular Dystrophy

GSK cutting 720 jobs in manufacturing, R&D and support functions at massive Belgian vaccine hub

Fierce Pharma

Thu, 02/6/20 - 11:53 am

23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales

Forbes

Thu, 01/23/20 - 11:48 pm

Otsuka's Avanir unit plots 140 layoffs in wake of $116M Nuedexta settlement

Fierce Pharma

Fri, 01/10/20 - 11:57 pm

Avanir Pharmaceuticals

Aduro's staffers feel the sting, again, after Novartis walks away

Fierce Biotech

Fri, 01/10/20 - 10:35 am

Regeneron to lay off field staffers as it restructures Sanofi partnership

Fierce Pharma

Thu, 01/2/20 - 11:03 am

Shares of Neon Therapeutics rise on restructuring plans

Marketwatch

Thu, 11/21/19 - 10:33 am

Neon Therapeutics

Hit by copycat meds, Amgen trims 172 more jobs, this time in operations, R&D and sales

Fierce Pharma

Tue, 11/19/19 - 10:28 am

Novartis Cuts 150 Jobs As it Shifts Focus of Shanghai Facility to Drug Development

BioSpace

Mon, 11/18/19 - 11:36 pm

Merck to slash more than 100 R&D jobs from French site: report

Fierce Biotech

Wed, 11/13/19 - 10:05 am

Amgen to cut 149 staff in retreat from neuroscience R&D

Fierce Biotech

Tue, 11/12/19 - 10:04 am

Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3; 55% of Workforce to be Cut

Xconomy

Mon, 11/4/19 - 10:42 am

Halozyme Therapeutics

pancreatic cancer

clinical trials

With 2 Failed Trials, Cyclerion Announces Plans to Cut 30 Out of 135 Jobs

BioSpace

Wed, 10/30/19 - 11:04 pm

clinical trials

diabetic neuropathy

Alkermes to lay off 160 in cost-cutting restructure

Biopharma Dive

Wed, 10/23/19 - 02:57 pm

Pages